Corrigendum: Comparison of chosen activation markers of human monocytes/macrophages isolated from the peripheral blood of young and elderly volunteers (Pharmacological Reports (2014) 66(5) (759–765) (S1734114014001649) (10.1016/j.pharep.2014.04.008));Comparison of chosen activation markers of human monocytes/macrophages isolated from the peripheral blood of young and elderly volunteers

Pharmacological Reports

Volumn 66, Issue 5, 2014, Pages 759-765

  Suchy, Dariusz ^a   Łabuzek, Krzysztof ^a   Bułdak, Łukasz ^a   Szkudłapski, Dawid ^a   Okopień, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Activation markers; Lipopolysaccharide; Macrophage; Monocyte

Indexed keywords

ARGINASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING 1; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ADULT; AGING; ARGINASE 1 GENE; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL STIMULATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; INTERLEUKIN 1BETA GENE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MONOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; SUPPRESSOR OF CYTOKINE SIGNALING 1 GENE; AGE; AGED; CELL CULTURE; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGE FACTORS; AGED; AGING; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 84903156812     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2017.02.009     Document Type: Erratum

References (26)

1. D. Aw, A.B. Silva, and D.B. Palmer Immunosenescence: emerging challenges for an ageing population Immunology 120 4 2007 435 446 (Pubitemid 46365019)
2. S.C. Castle Clinical relevance of age-related immune dysfunction Clin Infect Dis 31 2 2000 578 585 (Pubitemid 32289594)
3. A. Larbi, C. Franceschi, D. Mazzatti, R. Solana, A. Wikby, and G. Pawelec Aging of the immune system as a prognostic factor for human longevity Physiology (Bethesda) 23 2008 64 74
4. C. Franceschi, M. Capri, D. Monti, S. Giunta, F. Olivieri, and F. Sevini et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans Mech Ageing Dev 128 1 2007 92 105 (Pubitemid 46073065)
5. S. Vasto, G. Candore, C.R. Balistreri, M. Caruso, G. Colonna-Romano, and M.P. Grimaldi et al. Inflammatory networks in ageing, age-related diseases and longevity Mech Ageing Dev 128 1 2007 83 91 (Pubitemid 46073064)
6. R.D. Stout, and J. Suttles Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes Immunol Rev 205 2005 60 71 (Pubitemid 40780177)
7. T.P. Plackett, E.D. Boehmer, D.E. Faunce, and E.J. Kovacs Aging and innate immune cells J Leukoc Biol 76 2 2004 291 299 (Pubitemid 39006941)
8. J.P. Edwards, X. Zhang, K.A. Frauwirth, and D.M. Mosser Biochemical and functional characterization of three activated macrophage populations J Leukoc Biol 80 6 2006 1298 1307 (Pubitemid 44904968)
9. A.J. Rees Monocyte and macrophage biology: an overview Semin Nephrol 30 3 2010 216 233
10. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 12 2005 953 964 (Pubitemid 41746764)
11. A. Varin, and S. Gordon Alternative activation of macrophages: immune function and cellular biology Immunobiology 214 7 2009 630 641
12. K. Łabuzek, D. Suchy, B. Gabryel, O. Pierzchała, and B. Okopień Role of the SOCS in monocytes/macrophages-related pathologies. Are we getting closer to a new pharmacological target? Pharmacol Rep 64 5 2012 1038 1054
13. C.S. Whyte, E.T. Bishop, D. Rückerl, S. Gaspar-Pereira, R.N. Barker, and J.E. Allen et al. Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function J Leukoc Biol 90 5 2011 845 854
14. B. Okopień, J. Kowalski, R. Krysiak, K. Łabuzek, A. Stachura-Kułach, and A. Kułach et al. Monocyte suppressing action of fenofibrate Pharmacol Rep 57 3 2005 367 372 (Pubitemid 41030697)
15. R.W. Flø, A. Naess, F. Lund-Johansen, B.O. Maehle, H. Sjursen, and V. Lehmann et al. Negative selection of human monocytes using magnetic particles covered by anti-lymphocyte antibodies J Immunol Methods 137 1 1991 69 94
16. K. Łabuzek, S. Liber, Ł. Bułdak, G. Machnik, J. Liber, and B. Okopień Eplerenone promotes alternative activation in human monocyte-derived macrophages Pharmacol Rep 65 1 2013 226 234
17. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 1-2 1983 55 63 (Pubitemid 14203433)
18. P. Chomczyński, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1 1987 156 159 (Pubitemid 17064313)
19. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding Anal Biochem 72 1976 248 251
20. H.S. Smallwood, D. López-Ferrer, and T.C. Squier Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways Biochemistry 50 45 2011 9911 9922
21. P. Yoon, K.T. Keylock, M.E. Hartman, G.G. Freund, and J.A. Woods Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT Mech Ageing Dev 125 2 2004 137 143 (Pubitemid 38177575)
22. A. Kumar, B.A. Stoica, B. Sabirzhanov, M.P. Burns, A.I. Faden, and D.J. Loane Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states Neurobiol Aging 34 5 2013 1397 1411
23. A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J Clin Invest 106 4 2000 523 531 (Pubitemid 30666385)
24. E. Lutgens, D. Lievens, L. Beckers, E. Wijnands, O. Soehnlein, and A. Zernecke et al. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile J Exp Med 207 2 2010 391 404
25. M.V. Schmidt, B. Brüne, and A. von Knethen The nuclear hormone receptor PPARγ as a therapeutic target in major diseases Sci World J 10 2010 2181 2197
26. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 3 2012 787 795